back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-09 18:30 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
240,000 | |
| Filed 2025-08-22 18:20 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
270,000 | |
| Filed 2025-07-16 18:58 Tx date 2025-07-16 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+28,495 vol |
178,326 | |
| Filed 2025-07-16 18:55 Tx date 2025-07-16 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-28,495 vol |
0 | |
| Filed 2025-07-16 18:55 Tx date 2025-07-14 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+28,495 vol |
28,495 | |
| Filed 2025-04-22 18:22 Tx date 2025-04-21 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+27,906 vol |
149,831 | |
| Filed 2025-04-22 18:20 Tx date 2025-04-21 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-27,906 vol |
0 | |
| Filed 2025-04-04 17:43 Tx date 2025-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+27,906 vol |
27,906 | |
| Filed 2024-12-20 16:47 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,900
+30,000 vol $1.13 each |
120,000 | |
| Filed 2024-06-19 09:42 Tx date 2024-06-18 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-5,263 vol |
90,000 | |
| Filed 2023-08-18 11:26 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+30,000 vol $2.76 each |
95,263 | |
| Filed 2022-06-21 15:40 Tx date 2022-06-20 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,200
+30,000 vol $1.14 each |
65,263 | |
| Filed 2022-01-04 14:24 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,142 vol |
121,925 | |
| Filed 2022-01-04 14:22 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,142 vol |
0 | |
| Filed 2021-10-04 18:09 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,134 vol |
118,783 | |
| Filed 2021-10-04 18:08 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,134 vol |
3,142 | |
| Filed 2021-10-04 18:07 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,313 vol |
110,649 | |
| Filed 2021-10-04 18:04 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,313 vol |
11,276 | |
| Filed 2021-06-30 16:00 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,313 vol |
13,589 | |
| Filed 2021-06-30 11:25 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,933
+2,313 vol $3.43 each |
5,313 |